1. Home
  2. Labeler Index
  3. Amgen, Inc
  4. 55513-056
  5. NDC Package Code: 55513-056-96 Pavblu

NDC Package 55513-056-96 Pavblu

Aflibercept-ayyh Injection, Solution Intravitreal - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
55513-056-96
Package Description:
1 SYRINGE in 1 CARTON / .05 mL in 1 SYRINGE
Product Code:
55513-056
Proprietary Name:
Pavblu
Non-Proprietary Name:
Aflibercept-ayyh
Substance Name:
Aflibercept
Usage Information:
Aflibercept is used to treat certain serious eye conditions (such as wet age-related macular degeneration, diabetic retinopathy/macular edema, macular edema following retinal vein occlusion). This medication can help preserve vision and prevent blindness. Aflibercept belongs to a class of drugs known as growth factor inhibitors. It works by slowing the growth of abnormal new blood vessels in the eye and decreasing leakage from these blood vessels.
11-Digit NDC Billing Format:
55513005696
NDC to RxNorm Crosswalk:
Product Type:
Human Prescription Drug
Labeler Name:
Amgen, Inc
Dosage Form:
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Administration Route(s):
Intravitreal - Administration within the vitreous body of the eye.
Active Ingredient(s):
AFLIBERCEPT 2 mg/.05mL
Pharmacologic Class(es):
Sample Package:
Yes
FDA Application Number:
BLA761298
Marketing Category:
BLA - A product marketed under an approved Biologic License Application.
Start Marketing Date:
10-28-2024
Listing Expiration Date:
12-31-2026
Exclude Flag:
N
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Other Product Packages

The following packages are also available for this product:

NDC Package CodePackage Description
55513-056-011 SYRINGE in 1 CARTON / .05 mL in 1 SYRINGE

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 55513-056-96?

The NDC Packaged Code 55513-056-96 is assigned to a package of 1 syringe in 1 carton / .05 ml in 1 syringe of Pavblu, a human prescription drug labeled by Amgen, Inc. The product's dosage form is injection, solution and is administered via intravitreal form.

Is NDC 55513-056 included in the NDC Directory?

Yes, Pavblu with product code 55513-056 is active and included in the NDC Directory. The product was first marketed by Amgen, Inc on October 28, 2024 and its listing in the NDC Directory is set to expire on December 31, 2026 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 55513-056-96?

The 11-digit format is 55513005696. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-3-255513-056-965-4-255513-0056-96